Abstract:Protein PDZ and LIM domain 3 (PDLIM3) is a cytoskeletal protein, colocalizing with alpha-actinin on the Z line of mature muscle fibers. It plays a key role in dilated cardiomyopathy (DCM), muscular dystrophy, and tumor progression. However, correlations between PDLIM3 expression, prognosis, and tumor-infiltrating immune cells in gastric cancer are unknown. Therefore, we leveraged the Oncomine, GEPIA, GEO, and HPA databases to evaluate PDLIM3 expression in tumors. We also quantified PDLIM3 expression in 15 matched pairs of gastric tumor and nontumor tissues by immunohistochemistry. The Kaplan-Meier method was employed to determine the relationship between PDLIM3 expression and clinical outcomes. GO and KEGG analyses were performed to illuminate the molecular mechanisms of action of PDLIM3. TIMER2.0 and GEPIA were applied to investigate correlations between PDLIM3 expression and gene marker subsets signifying immune infiltration, with TIMER2.0 exploring the correlations between PDLIM3 and related signaling pathways. Gastric cancer tissues were found to express more PDLIM3 than nontumor tissues. PDLIM3 overexpression was associated with shorter OS and PFS of gastric cancer patients (OS HR=2.02, P=9.8e-10; PFS HR=1.77, P=7.5e-06). PDLIM3 was also positively correlated with worse OS and PFS according to gastric cancer staging, Her-2 overexpression, differentiation grade, and Lauren classification. PDLIM3 was shown to be associated with immunological responses by GO, while it was related to PI3K/Akt signal pathways by KEGG analysis. Furthermore, increased PDLIM3 expression was significantly correlated with greater infiltration of CD4+ T cells, CD8+ T cells, macrophages, neutrophils, and dendritic cells. PDLIM3 expression had significant positive correlations with a variety of immune marker subsets. Finally, correlations were found between PDLIM3 and crucial markers of signaling pathways involving PI3K/Akt and p38 MAPK. Thus, upregulation of PDLIM3 was significantly associated with poor prognosis, immune cell infiltration, and activation of two key signal pathways in gastric cancer. We propose that PDLIM3 could be used as a biomarker to predict prognosis and immune cell infiltration in gastric cancer.

PDLIM1 Inhibits Chemoresistance by Blocking DNA Damage Repair in Gastric Cancer

Effects of Lncrna ANRIL-knockdown on the Proliferation, Apoptosis and Cell Cycle of Gastric Cancer Cells.

Gastric cancer derived mesenchymal stem cells promoted DNA repair and cisplatin resistance through up-regulating PD-L1/Rad51 in gastric cancer

Inhibition of PARP1 Activity Enhances Chemotherapeutic Efficiency in Cisplatin-Resistant Gastric Cancer Cells.

GLIPR1 modulates the response of cisplatin-resistant human lung cancer cells to cisplatin

PDLIM1 interacts with HK2 to promote gastric cancer progression through enhancing the Warburg effect via Wnt/β-catenin signaling

The Interaction Between PDCD4 and YB1 is Critical for Cervical Cancer Stemness and Cisplatin Resistance.

Downregulation of LINC01857 Increases Sensitivity of Gastric Carcinoma Cells to Cisplatin

LRPPRC Contributes to the Cisplatin Resistance of Lung Cancer Cells by Regulating MDR1 Expression

Ercc1 Sirna Ameliorates Drug Resistance to Cisplatin in Gastric Carcinoma Cell Lines

Knockdown of Cir_rna PVT1 Elevates Gastric Cancer Cisplatin Sensitivity Via Sponging Mir-152-3p.

Knockdown of PD-L1 in Human Gastric Cancer Cells Inhibits Tumor Progression and Improves the Cytotoxic Sensitivity to CIK Therapy.

Increase in Cisplatin Resistance by MeCP2 in Human Gastric Cancer Through the Activation of the AKT Pathway by Facilitating PDK-1 Transcription

MiR-34a-5p/PD-L1 Axis Regulates Cisplatin Chemoresistance of Ovarian Cancer Cells.

Knockdown of RAP2A gene expression suppresses cisplatin resistance in gastric cancer cells

Wee1 Inhibitor AZD1775 Combined with Cisplatin Potentiates Anticancer Activity Against Gastric Cancer by Increasing DNA Damage and Cell Apoptosis

Regulation of growth of gastric cancer cells and sensitivity to cisplatin by modulation of DNA binding inhibitor or differentiation protein expression

Comprehensive Analysis of PDLIM3 Expression Profile, Prognostic Value, and Correlations with Immune Infiltrates in Gastric Cancer

DCTPP1 Attenuates the Sensitivity of Human Gastric Cancer Cells to 5-Fluorouracil by Up-Regulating MDR1 Expression Epigenetically.

PDLIM1 Stabilizes the E-Cadherin/β-Catenin Complex to Prevent Epithelial–Mesenchymal Transition and Metastatic Potential of Colorectal Cancer Cells

DKK1 Promotes Epithelial–Mesenchymal Transition and Cisplatin Resistance in Gastric Cancer via Activation of the PI3K/AKT Pathway